Gene expression profiling and multiple myeloma

John Shaughnessy, Fenghuang Zhan, Barthel Barlogie, A. K. Stewart

Research output: Contribution to journalReview articlepeer-review

18 Scopus citations


Gene expression profiling is a powerful tool through which the biology of multiple myeloma can be dissected. We will describe in this chapter how early studies using this technology have provided meaningful insights into myeloma biology, have led to the identification of new therapeutic targets, and have identified powerful prognostic and pharmacogenomic markers. Specifically, we will demonstrate that gene expression profiling can be used to segregate myeloma patients into prognostic categories within which known IgH translocation signatures can be readily defined. We also show that expression signatures can identify patients with chromosome 13 deletion. Finally, we demonstrate that global gene expression signatures can be distilled to short lists of three genes or more which together impart clinical outcome information, which is significantly more powerful than any previously defined prognostic tool. Expression profiling has also led to the identification of a number of new therapeutic targets not only in myeloma cell survival but also in the pathogenesis of the osteolysis which is a hallmark of this disease.

Original languageEnglish (US)
Pages (from-to)537-552
Number of pages16
JournalBest Practice and Research: Clinical Haematology
Issue number4 SPEC. ISS.
StatePublished - Dec 2005


  • CHCL1
  • Chromosome 13
  • DKK-1
  • Gene expression
  • Immunoglobulin
  • MGUS
  • Myeloma
  • RAN
  • Unfolded protein response
  • XBP-1
  • ZHX-2

ASJC Scopus subject areas

  • Oncology
  • Clinical Biochemistry


Dive into the research topics of 'Gene expression profiling and multiple myeloma'. Together they form a unique fingerprint.

Cite this